Safety and Immunogenicity of S-Trimer (SCB-2019), a Protein Subunit Vaccine Candidate for COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Immunogenicity of S-Trimer (SCB-2019), a Protein Subunit Vaccine Candidate for COVID-19 in Healthy Adults: A Phase 1, Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 2021 Jan 29;[EPub Ahead of Print], P Richmond, L Hatchuel, M Dong, B Ma, B Hu, I Smolenov, P Li, P Liang, HH Han, J Liang, R ClemensFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.